Mayo Clinic - Arizona Cancer Clinical Research Unit
Scottsdale, Arizona, United States
Research institute in Scottsdale, Arizona
13208 E Shea Blvd, Scottsdale, AZ 85259
About Mayo Clinic - Arizona Cancer Clinical Research Unit
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Novartis Pharmaceuticals
2
Celldex Therapeutics
1
Clinical Trials at Mayo Clinic - Arizona Cancer Clinical Research Unit
During the past decade, Mayo Clinic - Arizona Cancer Clinical Research Unit conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma.
2008-07-01
2011-01-01
Completed
29
A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients
2009-01-01
2011-12-01
Completed
28
A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers
2011-10-01
2017-10-16
Completed
90
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Mayo Clinic - Arizona Cancer Clinical Research Unit
According to Clinical.Site data, the most researched conditions in "Mayo Clinic - Arizona Cancer Clinical Research Unit" are
"Any T-cell Malignancy" (1 trials), "Burkett's Lymphoma" (1 trials), "CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Colorectal Adenocarcinoma, Non-small Cell Lung Cancer)" (1 trials). Many other conditions were trialed in "Mayo Clinic - Arizona Cancer Clinical Research Unit" in a lesser frequency.
Clinical Trials Intervention Types at Mayo Clinic - Arizona Cancer Clinical Research Unit
Most popular intervention types in "Mayo Clinic - Arizona Cancer Clinical Research Unit" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "AUY922" (1 trials), "BHQ880" (1 trials), "Bortezomib" (1 trials), "CDX-1127" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mayo Clinic - Arizona Cancer Clinical Research Unit
The vast majority of trials in "Mayo Clinic - Arizona Cancer Clinical Research Unit" are
3 trials for "All" genders.
Clinical Trials Status at Mayo Clinic - Arizona Cancer Clinical Research Unit
Currently, there are NaN active trials in "Mayo Clinic - Arizona Cancer Clinical Research Unit".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Mayo Clinic - Arizona Cancer Clinical Research Unit,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Mayo Clinic - Arizona Cancer Clinical Research Unit, 3 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".